Print Page   |   Contact Us   |   Sign In
Community Search
Sign In


7/1/2020 » 12/31/2020
ON-DEMAND: End-of-Life Planning and COVID-19: It is never too soon to think about what matters most

7/1/2020 » 12/31/2020
ON-DEMAND: Education is 90% of Our Job with Barbara Karnes, RN

WEBINAR: Surviving COVID-19 and Beyond with Judi Lund Person, MPH, CHC

WEBINAR: Putting Volunteers at the Center

WEBINAR: Motivating Employees: It's Not What You Think

For Physicians: Determing Terminal Status
Share |

Determining Terminal Status

Medicare coverage of hospice depends on a physician’s certification that an individual’s prognosis is a life expectancy of six months or less if the terminal illness runs its normal course. The Local Coverage Determination for Hospice (LCD) describes guidelines to be used by Regional Home Health Intermediaries in reviewing hospice claims and by hospice providers to determine eligibility of beneficiaries for hospice benefits. Although guidelines applicable to certain disease categories are included, the LCD is applicable to all hospice patients. It is intended to be used to identify any Medicare beneficiary whose current clinical status and anticipated progression of disease is more likely than not to result in a life expectancy of six months or less.

Clinical variables with general applicability without regard to diagnosis, as well as clinical variables applicable to a limited number of specific diagnoses, are provided. Patients who meet the guidelines established herein are expected to have a life expectancy of six months or less if the terminal illness runs its normal course. Some patients may not meet these guidelines, yet still have a life expectancy of 6 months or less. Coverage for these patients may be approved if documentation of clinical factors supporting a less than 6-month life expectancy not included in these guidelines is provided.

If a patient improves or stabilizes sufficiently over time while in hospice such that he/she no longer has a prognosis of six months or less from the most recent recertification evaluation or definitive interim evaluation, that patient should be considered for discharge from the Medicare hospice benefit. Such patients can be re-enrolled for a new benefit period when a decline in their clinical status is such that their life expectancy is again six months or less. On the other hand, patients in the terminal stage of their illness who originally qualify for the Medicare hospice benefit but stabilize or improve while receiving hospice care, yet have a reasonable expectation of continued decline for a life expectancy of less than six months, remain eligible for hospice care.